Medical Properties Trust, Inc. (MPT) Stock Analysis
Real Estate · REIT - Healthcare Facilities
Sell if holding. Analyst target reached at $5.00 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5.
Medical Properties Trust is a self-advised healthcare REIT with 384 facilities across 31 US states, 7 European countries, and Colombia, leased to operators under long-term net leases. Total assets were $15B at December 31, 2025; rent billed = 75.8% of $972M total revenues.... Read more
Sell if holding. Analyst target reached at $5.00 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5. Chart setup: No clear chart pattern; technical signals are mixed. Score 5.4/10, high confidence.
Passes 6/8 gates (clean insider activity, no SEC red flags, news events none recent, earnings proximity 48d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum and favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-06-11Recent Developments — Medical Properties Trust, Inc.
Latest news
- NEWS Medical Properties Trust: From Crisis To Comeback (NYSE:MPT) - Seeking Alpha — Seeking Alpha positive
- NEWS Medical Properties Trust Q4 earnings, revenue beat as Prospect issues resolved - MSN — MSN positive
- NEWS Securities Fraud Investigation Into Medical Properties - GlobeNewswire — GlobeNewswire negative
- NEWS Why Medical (MPT) Stock Matters (Investors Pile In) 2026-04-20 - Entry Points - Cổng thông tin điện tử tỉnh Tây Ninh — Cổng thông tin điện tử tỉnh Tây Ninh neutral
- NEWS Medical Properties (MPT) Q4 FFO and revenues surpass estimates - MSN — MSN positive
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
2 floor-breakers
Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $5.00 — A.R:R 0.1:1 is below the 1.5:1 minimum. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Leverage penalty (D/E 2.1): -1.5. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $4.78. Score 5.4/10, high confidence.
Take-profit target: $5.03 (+0.6% upside). Prior stop was $4.78. Stop-loss: $4.78.
Analyst target reached - limited upside remaining; Leverage penalty (D/E 2.1): -1.5; Consecutive earnings misses (2).
Medical Properties Trust, Inc. trades at a P/E of N/A (forward 34.0). TrendMatrix value score: 5.7/10. Verdict: Sell.
16 analysts cover MPT with a consensus score of 2.7/5. Average price target: $6.
What does Medical Properties Trust, Inc. do?Medical Properties Trust is a self-advised healthcare REIT with 384 facilities across 31 US states, 7 European...
Medical Properties Trust is a self-advised healthcare REIT with 384 facilities across 31 US states, 7 European countries, and Colombia, leased to operators under long-term net leases. Total assets were $15B at December 31, 2025; rent billed = 75.8% of $972M total revenues. Circle (UK, 14.1% of assets), Priory (UK, 8.7%), and HSA (US, 8.0%) are the three largest tenants.